Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

K. Oechsle; F. Honecker; T. Cheng; F. Mayer; P. Czaykowski; E. Winquist; L. Wood; M. Fenner; S. Glaesener; J. T. Hartmann; K. Chi; C. Bokemeyer; C. Kollmannsberger

doi:10.1093/annonc/mdr026

Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

K. Oechsle, F. Honecker, T. Cheng, F. Mayer, P. Czaykowski, E. Winquist, L. Wood, M. Fenner, S. Glaesener, J. T. Hartmann, K. Chi, C. Bokemeyer, C. Kollmannsberger

Research output: Contribution to journal › Article › peer-review

78 Citations (Scopus)

Original language	English
Pages (from-to)	2654-2660
Number of pages	7
Journal	Annals of Oncology
Volume	22
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdr026
Publication status	Published - Dec 2011
Externally published	Yes

ASJC Scopus Subject Areas

Hematology
Oncology

Keywords

Angiogenesis
Cisplatin resistance
Germ cell tumor
Relapse
Sunitinib

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdr026

Fingerprint

Dive into the research topics of 'Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study'. Together they form a unique fingerprint.

Cite this

Oechsle, K., Honecker, F., Cheng, T., Mayer, F., Czaykowski, P., Winquist, E., Wood, L., Fenner, M., Glaesener, S., Hartmann, J. T., Chi, K., Bokemeyer, C., & Kollmannsberger, C. (2011). Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study. Annals of Oncology, 22(12), 2654-2660. https://doi.org/10.1093/annonc/mdr026

Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study. / Oechsle, K.; Honecker, F.; Cheng, T. et al.
In: Annals of Oncology, Vol. 22, No. 12, 12.2011, p. 2654-2660.

Research output: Contribution to journal › Article › peer-review

Oechsle, K, Honecker, F, Cheng, T, Mayer, F, Czaykowski, P, Winquist, E, Wood, L, Fenner, M, Glaesener, S, Hartmann, JT, Chi, K, Bokemeyer, C & Kollmannsberger, C 2011, 'Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study', Annals of Oncology, vol. 22, no. 12, pp. 2654-2660. https://doi.org/10.1093/annonc/mdr026

@article{f07cd27a6c454e4eade6d197fc31269e,

title = "Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study",

keywords = "Angiogenesis, Cisplatin resistance, Germ cell tumor, Relapse, Sunitinib",

author = "K. Oechsle and F. Honecker and T. Cheng and F. Mayer and P. Czaykowski and E. Winquist and L. Wood and M. Fenner and S. Glaesener and Hartmann, {J. T.} and K. Chi and C. Bokemeyer and C. Kollmannsberger",

note = "Funding Information: Pfizer Inc., New York (investigator-initiated research grant).",

year = "2011",

month = dec,

doi = "10.1093/annonc/mdr026",

language = "English",

volume = "22",

pages = "2654--2660",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors

T2 - A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

AU - Oechsle, K.

AU - Honecker, F.

AU - Cheng, T.

AU - Mayer, F.

AU - Czaykowski, P.

AU - Winquist, E.

AU - Wood, L.

AU - Fenner, M.

AU - Glaesener, S.

AU - Hartmann, J. T.

AU - Chi, K.

AU - Bokemeyer, C.

AU - Kollmannsberger, C.

N1 - Funding Information: Pfizer Inc., New York (investigator-initiated research grant).

PY - 2011/12

Y1 - 2011/12

KW - Angiogenesis

KW - Cisplatin resistance

KW - Germ cell tumor

KW - Relapse

KW - Sunitinib

UR - http://www.scopus.com/inward/record.url?scp=79960860865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960860865&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdr026

DO - 10.1093/annonc/mdr026

M3 - Article

C2 - 21415240

AN - SCOPUS:79960860865

SN - 0923-7534

VL - 22

SP - 2654

EP - 2660

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this